Integration/Diversification: NeutralVertically integrated: yes they produce and will eventually sell through online platform.
Horizontally diversified: eventually perhaps yes, with medical and blockchain pursuits.

Financials: Weak (still very low revenue)

Management: Strong

Branding: Neutralto Strong

Valuation: Weak (too high given state of production)

Recommendation: Neutral

Get the Q1, ’19 Cannin Report ($99)

Includes the latest market & industry update, 12 technical fundamental analyses, latest regulations by state, new medical research and more!

Previous ProjectEmblem Corp

Next ProjectFriday Night Inc.

Risk of Prosecution for Marijuana-Related Companies. If you are considering investing in a company that is connected to the marijuana industry, be aware that marijuana-related companies may be at risk of federal, and perhaps state, criminal prosecution. The Department of Treasury recently issued guidance noting: “[T]he Controlled Substances Act (“CSA”) makes it illegal under federal law to manufacture, distribute, or dispense marijuana. Many states impose and enforce similar prohibitions. Notwithstanding the federal ban, as of the date of this guidance, 20 states and the District of Columbia have legalized certain marijuana-related activity.”